CLBT

CLBT

USD

Cellebrite DI Ltd. Ordinary Shares

$16.240-0.010 (-0.062%)

实时价格

技术
Software - Infrastructure
以色列

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$16.250

最高价

$16.305

最低价

$15.895

成交量

1.34M

公司基本面

市值

3.9B

所属行业

Software - Infrastructure

国家/地区

Israel

交易统计

平均成交量

1.24M

交易所

NMS

货币

USD

52周价格范围

最低价 $11.47当前价 $16.240最高价 $26.3

AI分析报告

最后更新: 2025年5月23日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

CLBT (Cellebrite DI Ltd. Ordinary Shares): Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLBT Generate Date: 2025-05-23 02:01:22

Let's break down what's been happening with Cellebrite's stock lately and what the signals might be suggesting. Think of this as looking under the hood to see what's driving things.

Recent News Buzz: What's the Vibe?

Looking at the latest headlines, the feeling around Cellebrite is a bit mixed, but leans positive in terms of company activity and sentiment.

  • First off, the company is getting out there, announcing they'll be at upcoming investor conferences. That's pretty standard stuff, showing they're engaging with the financial community. It's generally seen as a neutral to slightly positive sign.
  • Then there's news about a new product release – their "Spring 2025 Release." Companies putting out new stuff is usually good news, especially for a tech firm like Cellebrite which is all about digital investigation solutions. It suggests innovation and trying to stay ahead.
  • However, we also saw an analyst from Needham maintain their "Buy" rating on the stock, which sounds great, but they actually lowered their price target from $28 down to $24. So, while they still think it's a stock to buy, they see less potential upside than before. That's a bit of a dampener.

Putting it together, the news shows the company is active and innovating, which is positive. An analyst still likes the stock enough to recommend buying, but the lowered target is a yellow flag. Interestingly, the AI analysis of recent news sentiment comes back as "highly positive," suggesting the overall feeling from the news flow is upbeat despite that lowered price target.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock price itself over the last few months.

Back in late February and March, the stock was mostly trading in the $18-$19 range, sometimes pushing above $20 in late March and early April. It had a decent run there for a bit.

But then, around the middle of May (right when that analyst note came out, actually), the price took a pretty sharp dive. It dropped from around $20 down into the $17 range quite quickly. Since that drop, it's been trading mostly sideways, bouncing between roughly $16.70 and $17.50. The last recorded price was around $16.71.

So, the recent trend is clearly down from its April highs, followed by a period of trying to find its footing at a lower level.

Now, here's where it gets interesting: the AI prediction for the next few days is quite bullish. It forecasts price increases of around 1.45% today, 2.86% tomorrow, and 3.96% the day after. This suggests the AI sees potential for a bounce or a short-term upward move from these current lower prices.

Outlook & Ideas: Putting It All Together

Okay, so we have a mix of signals: positive company news (product, investor engagement), mixed analyst view (Buy but lower target), a recent sharp price drop, and a bullish short-term AI prediction.

Based on this specific data, the apparent near-term leaning seems to be cautiously positive, primarily driven by the strong AI prediction for the next few days and the positive news sentiment score, despite the recent price weakness and the analyst's lowered target. The AI seems to think the recent dip might be a temporary thing and sees room for a bounce.

  • Potential Entry Consideration: If you were looking at this stock and found the AI's bullish short-term outlook compelling, the current price area (around $16.70) or slightly higher (like the $17.11-$17.20 range mentioned in the recommendation data) could be considered as potential entry points. Why? Because it's right where the stock has been trading recently after the dip, and the AI predicts it will go up from here. The recommendation data also points to $17.08 as a potential support level, which is right in this neighborhood.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key.
    • For taking profits, the recommendation data suggests a very near-term target of $17.38. This is close to the recent trading range high and could be a target for a quick bounce trade. Looking further out, the analyst's lowered target is $24, and the AI's projected target is $24.54. These are much higher and would require a significant, sustained upward move, but they give an idea of potential upside if the trend really reverses.
    • For cutting losses (a stop-loss), the recommendation data suggests $15.33. This level is below the recent lows seen during the May 14th drop. If the stock falls below this point, it might signal that the recent weakness is continuing, and the bullish AI prediction isn't playing out.

Company Context

Just a quick reminder about Cellebrite: they are a tech company focused on digital investigation tools. They help law enforcement and companies access and analyze digital data for legal cases. This means their business can be influenced by government spending, cybersecurity trends, and the need for digital evidence in investigations. The new product release fits right into this core business.

Remember, this analysis is based only on the provided data points – the news, the recent price history, and the AI predictions/recommendations.


Disclaimer: This report is for informational purposes only and is based on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

相关新闻

Analyst Upgrades

Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target

Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $24 price target.

查看更多
Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target
GlobeNewswire

Cellebrite to Acquire Corellium

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its

查看更多
Cellebrite to Acquire Corellium
GlobeNewswire

Cellebrite Announces Participation in Upcoming Investor Conferences

TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that

查看更多
Cellebrite Announces Participation in Upcoming Investor Conferences

AI预测Beta

AI建议

看涨

更新于: 2025年6月13日 01:38

看跌中性看涨

69.6% 置信度

风险与交易

风险等级3/5
中风险
适合于
增长
交易指南

入场点

$16.22

止盈点

$16.56

止损点

$14.62

关键因素

PDI 6.7高于MDI 4.7,且ADX 25.5,表明看涨趋势
当前价格非常接近支撑水平$16.18,表明有强烈的买入机会
交易量是平均值的8.5倍(15,355),表明极强的买入压力
MACD 0.0342低于信号线0.0349,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。